Speaker Profile
Biography
Dr. Montalto is an industry leader in translational and precision medicine, digital pathology and AI for biomarker discovery.
Prior to Amgen, Dr. Montalto was the Chief Scientific Officer of PathAI, and Vice President of Translational Sciences at Bristol Myers Squibb. He has led teams to invent, develop and launch digital pathology, spatial multiplexing and AI-powered software applications as well as flagship biomarker testing programs such as PharmDx 28-8 (PD-L1/Agilent) for Opdivo, Yervoy and Opdualag.
Dr. Montalto serves on the Executive Committee of FNIH Biomarker Consortium, the editorial board of the Journal of AI in Precision Oncology and is a member of the Friends of Cancer Research Digital Pathology Working Group. He is the former President and board member of the Digital Pathology Association, has served as a scientific advisor to various multinational and start-up companies, holds 10 U.S. patents and has authored over 100 publications.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Hal Paz, Khosla Ventures
PMWC Award Ceremony
• Victor Dzau, National Academy of Medicine (Luminary)
Featured Speakers
• Victor Dzau, National Academy of Medicine
• Hal Paz, Khosla Ventures
• David Feinberg, Oracle
• Dan Knecht, EmblemHealth
• Mike Montalto, Amgen
• Michael Pfeffer, Stanford
• Burns Blaxall, Cincinnati Children's
• Peter Hulick, Endeavor Health
• Hilary Gee Goeckner, ACS CAN
• Gary Marchant, Arizona State University
• Connie Lehman, Clairity
Operating Models That Actually Work
What it takes to run precision medicine across a health system.
What Gets Covered and Why
Coverage, payment pathways, and the evidence payers act on.
CDS That Clinicians Will Use
Putting the right guidance in front of the right clinician at the right time.
From Biomarker to Standard of Care
The evidence and operations that move a test into routine use.
What Will the Next Generation of Health Systems Build?
The precision-medicine roadmap for the decade ahead.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.